Q2 2023 Holdings
Filed 2023-07-19 | 7 holdings | $76.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Dyne Therapeutics, Inc.(DYN) | Common Stock | 26818M108 | $25.0M | 2,220,034 | 32.6% |
| Centessa Pharmaceuticals plc(CNTA) | Ordinary Shares | 152309100 | $24.3M | 3,931,818 | 31.8% |
| Allogene Therapeutics, Inc.(ALLO) | Common Stock | 019770106 | $8.9M | 1,798,163 | 11.7% |
| Kinnate Biopharma, Inc. | Common Stock | 49705R105 | $6.7M | 2,207,772 | 8.7% |
| LianBio | Ordinary Shares | 53000N108 | $5.2M | 2,282,084 | 6.8% |
| Kronos Bio, Inc.(KRON1USD) | Common Stock | 50107A104 | $4.8M | 2,765,314 | 6.2% |
| Praxis Precision Medicines, Inc. | Common Stock | 74006W108 | $1.7M | 1,469,665 | 2.2% |